search
Back to results

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

Primary Purpose

Childhood Cancer, Mobility Limitation

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise testing results
Individually tailored exercise program (INT)
Generalized exercise recommendations (AC)
Sponsored by
St. Jude Children's Research Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Childhood Cancer

Eligibility Criteria

18 Years - 39 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Between 18.00 and 39.99 years of age at the time of enrollment
  • SJLIFE participant
  • Peak VO2 <85% predicted
  • Verbalizes understanding of directions for use of ZOOM on the study provided iPad and heart rate monitor
  • Clearance for participation in exercise by a study physician
  • Internet access

Exclusion Criteria:

  • Enrolled in a formal exercise intervention
  • Self-report of engaging in > 150 minutes/week of moderate physical activity
  • Currently pregnant (assess by urine pregnancy test)
  • Significant psychological distress (e.g. suicidal ideation)
  • Requires immediate medical intervention (e.g. angina, decompensated heart failure)
  • Research Participant Recruitment and Screening

Sites / Locations

  • St. Jude Children's Research HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Personalized exercise group (INTGroup)

Generalized exercise group, Attention Control (AC Group)

Arm Description

Participants in this group have individually tailored exercise program with supervision, 20 weeks,clinic 3 times during the course of this study: at baseline (this appointment), at 4 months and 10 months from now for follow-up.

Study participants in this group receive generalized exercise recommendations, 20 weeks,clinic 3 times during the course of this study: at baseline (this appointment), at 4 months and 10 months from now for follow-up.

Outcomes

Primary Outcome Measures

Exercise Capacity
Changes in Peak VO2/2-minute step in place test in both INT and AC groups
Exercise capacity
Sustainability of changes in Peak VO2/2-minute step in place test in both INT and AC groups

Secondary Outcome Measures

Patient Health Questionnaire (PHQ-9)
Scale: 4 Options - Not at all (minimum value = 0), Several days (1), More than half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-27.
Generalized Anxiety Disorder (GAD-7)
Scale: 5 Options - Not at all sure (minimum value = 0), Several days (1), Over half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-21.
PROMIS Ability to Participate 8a (SF v2.0)
Scale: 5 Options - Never (maximum value = 5), Rarely (4), Sometimes (3), Usually (2), Always (minimum value = 1). Higher score = better outcome. Possible score range 8-40.
Work Productivity and Activity Impairment Questionnaire (WPAI)
Scale doesn't apply to overall questionnaire. Outcomes are expressed as impairment percentages. Higher numbers = worse outcome.
Work and Social Adjustment Scale (WSAS)
Scale: 0-8; Not at all (minimum value = 0) to Very Severely (maximum value = 8). Higher score = worse outcome. Possible score range 0-40.
Medical Outcomes Survey Short Form (SF-36)
Consists of 8 scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. Higher score = better outcome.
Childhood Cancer Survivor Study Neurocognitive Questionnaire - Revised (CCSS-NCQ)
Scale: 3 Options - Never a Problem (maximum value = 2), Sometimes a Problem (1) , Often a Problem (minimum value = 0). Higher score = better outcome. Possible score range 0-64.
PROMIS Global Health Short Forms
brief global physical and mental health questionnaires; Scale: 5-point Likert scale, Excellent=5, Poor=1

Full Information

First Posted
March 10, 2020
Last Updated
February 16, 2023
Sponsor
St. Jude Children's Research Hospital
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT04714840
Brief Title
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
Official Title
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 8, 2021 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Jude Children's Research Hospital
Collaborators
National Cancer Institute (NCI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The participants are asked to take part in this clinical trial, a type of research study. The participants are SJLIFE study participants and may have a hard time exercising (exercise intolerance) due to side effects of cancer treatment received as a child.This study is being done to determine if a personalized exercise plan will help childhood cancer survivors who have exercise intolerance become more active. Primary Objectives: To achieve the goal of this study, we propose the following three Objectives: Primary Objective 1: To determine the efficacy of an individually tailored, home-delivered aerobic and strengthening intervention to improve exercise capacity in survivors of childhood cancer with exercise intolerance (peak oxygen uptake (peak VO2) <85% of age and sex predicted). Primary Objective 2: To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on measures of cardiac, pulmonary, musculoskeletal, and neurosensory function in survivors of childhood cancer with exercise intolerance. Primary Objective 3: To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on emotional health, participation in family and community activities, quality of life, and cognitive function in survivors of childhood cancer with exercise intolerance.
Detailed Description
The design for this study will be a single-blind two-arm, prospective, randomized clinical trial. Performance testing results: Both groups of participants will be provided with the results of their performance testing. Individually tailored exercise program: Individuals randomized to receive an individually tailored exercise program will meet with an exercise specialist.Generalized exercise recommendations: Individuals randomized to receive the generalized exercise recommendations will receive a copy of the Physical Activity Guidelines for Americans.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Childhood Cancer, Mobility Limitation

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Personalized exercise group (INTGroup)
Arm Type
Other
Arm Description
Participants in this group have individually tailored exercise program with supervision, 20 weeks,clinic 3 times during the course of this study: at baseline (this appointment), at 4 months and 10 months from now for follow-up.
Arm Title
Generalized exercise group, Attention Control (AC Group)
Arm Type
Other
Arm Description
Study participants in this group receive generalized exercise recommendations, 20 weeks,clinic 3 times during the course of this study: at baseline (this appointment), at 4 months and 10 months from now for follow-up.
Intervention Type
Other
Intervention Name(s)
Exercise testing results
Intervention Description
Tailored, home-delivered aerobic and strengthening intervention,exercise intolerance,Both groups of participants will be provided with the results of their exercise testing.
Intervention Type
Other
Intervention Name(s)
Individually tailored exercise program (INT)
Intervention Description
Individuals randomized to receive an individually tailored exercise program will meet with an exercise specialist. Written instructions, videos of each strengthening exercise, a blue tooth enable heart rate monitor, all necessary exercise equipment, and an iPad pre-loaded with heart rate monitor software, exercise videos and ZOOM app (for video conferencing) will be provided. After returning home, the exercise specialist will supervise and provide guidance to the individual via the ZOOM app during the first 2 weeks (3 sessions per week). Supervision will slowly decrease to twice a week in weeks 3-4, once a week in weeks 5-8, every other week in weeks 9-16, and to one time midway between weeks 17-20. The exercise program will be adjusted depending on the individuals progress.
Intervention Type
Other
Intervention Name(s)
Generalized exercise recommendations (AC)
Intervention Description
Individuals randomized to receive the generalized exercise recommendations will receive a copy of the Physical Activity Guidelines for Americans. At the baseline visit, a study staff will review these guidelines and answer questions about their exercise testing and encourage them to be physically active. The staff will contact them via telephone to complete a short questionnaire weekly during weeks 1-8 and monthly for weeks 9-20.
Primary Outcome Measure Information:
Title
Exercise Capacity
Description
Changes in Peak VO2/2-minute step in place test in both INT and AC groups
Time Frame
Baseline to Week 20
Title
Exercise capacity
Description
Sustainability of changes in Peak VO2/2-minute step in place test in both INT and AC groups
Time Frame
Week 20 to 6 months after week 20
Secondary Outcome Measure Information:
Title
Patient Health Questionnaire (PHQ-9)
Description
Scale: 4 Options - Not at all (minimum value = 0), Several days (1), More than half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-27.
Time Frame
baseline, week 20, 6 months after week 20
Title
Generalized Anxiety Disorder (GAD-7)
Description
Scale: 5 Options - Not at all sure (minimum value = 0), Several days (1), Over half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-21.
Time Frame
baseline, week 20, 6 months after week 20
Title
PROMIS Ability to Participate 8a (SF v2.0)
Description
Scale: 5 Options - Never (maximum value = 5), Rarely (4), Sometimes (3), Usually (2), Always (minimum value = 1). Higher score = better outcome. Possible score range 8-40.
Time Frame
baseline, week 20, 6 months after week 20
Title
Work Productivity and Activity Impairment Questionnaire (WPAI)
Description
Scale doesn't apply to overall questionnaire. Outcomes are expressed as impairment percentages. Higher numbers = worse outcome.
Time Frame
baseline, week 20, 6 months after week 20
Title
Work and Social Adjustment Scale (WSAS)
Description
Scale: 0-8; Not at all (minimum value = 0) to Very Severely (maximum value = 8). Higher score = worse outcome. Possible score range 0-40.
Time Frame
baseline, week 20, 6 months after week 20
Title
Medical Outcomes Survey Short Form (SF-36)
Description
Consists of 8 scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. Higher score = better outcome.
Time Frame
baseline, week 20, 6 months after week 20
Title
Childhood Cancer Survivor Study Neurocognitive Questionnaire - Revised (CCSS-NCQ)
Description
Scale: 3 Options - Never a Problem (maximum value = 2), Sometimes a Problem (1) , Often a Problem (minimum value = 0). Higher score = better outcome. Possible score range 0-64.
Time Frame
baseline, week 20, 6 months after week 20
Title
PROMIS Global Health Short Forms
Description
brief global physical and mental health questionnaires; Scale: 5-point Likert scale, Excellent=5, Poor=1
Time Frame
weekly during the first eight weeks and every four weeks during weeks 9-20

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Between 18.00 and 39.99 years of age at the time of enrollment SJLIFE participant Peak VO2 <85% predicted Verbalizes understanding of directions for use of ZOOM on the study provided iPad and heart rate monitor Clearance for participation in exercise by a study physician Internet access Exclusion Criteria: Enrolled in a formal exercise intervention Self-report of engaging in > 150 minutes/week of moderate physical activity Currently pregnant (assess by urine pregnancy test) Significant psychological distress (e.g. suicidal ideation) Requires immediate medical intervention (e.g. angina, decompensated heart failure) Research Participant Recruitment and Screening
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kirsten Ness, PhD
Phone
866-278-5833
Email
referralinfo@stjude.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kirsten Ness, PhD
Organizational Affiliation
St. Jude Children's Research Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Jude Children's Research Hospital
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38105
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kirsten Ness, PhD
Phone
866-278-5833
Email
referralinfo@stjude.org
First Name & Middle Initial & Last Name & Degree
Kirsten Ness, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant de-identified datasets containing the variables analyzed in the published article will be made available (related to the study primary or secondary objectives contained in the publication). Supporting documents such as the protocol, statistical analyses plan, and informed consent are available through the CTG website for the specific study. Data used to generate the published article will be made available at the time of article publication. Investigators who seek access to individual level de-identified data will contact the computing team in the Department of Biostatistics (ClinTrialDataRequest@stjude.org) who will respond to the data request.
IPD Sharing Time Frame
Data will be made available at the time of article publication.
IPD Sharing Access Criteria
Data will be provided to researchers following a formal request with the following information: full name of requestor, affiliation, data set requested, and timing of when data is needed. As an informational point, the lead statistician and study principal investigator will be informed that primary results datasets have been requested.
Links:
URL
http://www.stjude.org
Description
St. Jude Children's Research Hospital
URL
http://www.stjude.org/protocols
Description
Clinical Trials Open at St. Jude

Learn more about this trial

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

We'll reach out to this number within 24 hrs